TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TeleLifestyleCoaching Use of Telemedicine for Weight Loss and Care of Weight Associated Illnesses
Brief Summary: Lifestyle changes often fail due to loss of motivation. Telemedicine and personal coaching have the potential to support lifestyle change and weight loss. Therefore, the aim of our randomized controlled trial was to examine the effect of telemedicine with and without coaching in comparison to a control group on weight loss in overweight participants.


Options:
A: Arm Label: control (C) group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: telemedical (TM) group; Type: EXPERIMENTAL; Interventions: Device: telemedical devices (weighing machine and step counter) | Arm Label: telemedical coaching (TMC) group; Type: EXPERIMENTAL; Interventions: Device: telemedical devices (weighing machine and step counter), Behavioral: care calls once per week for 12 weeks | Intervention Type: DEVICE; Name: telemedical devices (weighing machine and step counter); Assigned to Arm(s): telemedical (TM) group, telemedical coaching (TMC) group | Intervention Type: BEHAVIORAL; Name: care calls once per week for 12 weeks; Assigned to Arm(s): telemedical coaching (TMC) group
B: Arm Label: Physical activity treatment group; Type: EXPERIMENTAL; Interventions: Behavioral: Pedal@Work | Arm Label: Wait List Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Pedal@Work Worksite Wellness | Intervention Type: BEHAVIORAL; Name: Pedal@Work Worksite Wellness; Assigned to Arm(s): Wait List Control | Intervention Type: BEHAVIORAL; Name: Pedal@Work; Assigned to Arm(s): Physical activity treatment group
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ALIVE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ALIVE; Assigned to Arm(s): Intervention
D: Arm Label: Control group without advice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Computer-tailored physical activity advice; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity advice. | Intervention Type: BEHAVIORAL; Name: Physical Activity advice.; Assigned to Arm(s): Computer-tailored physical activity advice

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double-Masked, Placebo-Controlled, Efficacy And Safety Study Of RV 001, An Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antagonist Antibody (Fully Human), Administered Every 3 Weeks (q3W) By Intravenous (IV) Infusion In Patients Suffering From Active Thyroid Eye Disease (TED)
Brief Summary: The primary objective of this study is to investigate the efficacy, safety, and tolerability of RV 001 (teprotumumab), a fully human anti-IGF1R antibody, administered q3W for 6 months, in comparison to placebo, in the treatment of participants suffering from active TED.

"Funding Source - FDA OOPD"


Options:
A: Arm Label: Rituximab; Type: EXPERIMENTAL; Interventions: Drug: Rituximab, Drug: Methylprednisolone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Rituximab | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): Rituximab
B: Arm Label: Teprotumumab 20 mg/kg; Type: ACTIVE_COMPARATOR; Interventions: Biological: Teprotumumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: Teprotumumab; Assigned to Arm(s): Teprotumumab 20 mg/kg | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Rituximab Intravenous Infusion; Type: EXPERIMENTAL; Interventions: Drug: Anti-CD20 (rituximab) | Arm Label: Placebo Intravenous Infusion; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Comparator | Intervention Type: DRUG; Name: Anti-CD20 (rituximab); Assigned to Arm(s): Rituximab Intravenous Infusion | Intervention Type: DRUG; Name: Placebo Comparator; Assigned to Arm(s): Placebo Intravenous Infusion
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: normal saline | Arm Label: Teprotumumab; Type: EXPERIMENTAL; Interventions: Drug: teprotumumab | Intervention Type: DRUG; Name: teprotumumab; Assigned to Arm(s): Teprotumumab | Intervention Type: DRUG; Name: normal saline; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Shoes for Kids on the Island of Pemba (SKIP): A Pragmatic, Cluster Randomised Controlled Trial to Test if Shoes Reduce Hookworm Infection and Transmission in School-aged Children on Pemba Island, Zanzibar
Brief Summary: Small association studies have hypothesised that shoes protect against hookworm infection. The purpose of this pragmatic study was determine, under field conditions, whether school-age children on Pemba Island, Zanzibar, would wear shoes and if shoes protected them against hookworm infection.


Options:
A: Arm Label: Sanitation intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Provision of household latrines | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Provision of household latrines; Assigned to Arm(s): Sanitation intervention
B: Arm Label: Intervention group; Type: N/A; Interventions: Behavioral: Improved water supply and sanitation | Arm Label: Control group; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Improved water supply and sanitation; Assigned to Arm(s): Intervention group
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Shoes; Type: EXPERIMENTAL; Interventions: Device: Shoes | Intervention Type: DEVICE; Name: Shoes; Assigned to Arm(s): Shoes
D: Arm Label: Water Quality; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Water Quality | Arm Label: Sanitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Sanitation | Arm Label: Handwashing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Handwashing | Arm Label: Combined Water, Sanitation, and Handwashing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Water Quality, Behavioral: Sanitation, Behavioral: Handwashing | Arm Label: Nutrition; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Nutrition | Arm Label: Nutrition + Combined Water, Sanitation, and Handwashing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Water Quality, Behavioral: Sanitation, Behavioral: Handwashing, Dietary Supplement: Nutrition | Arm Label: Active control arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Passive control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Water Quality; Assigned to Arm(s): Combined Water, Sanitation, and Handwashing, Nutrition + Combined Water, Sanitation, and Handwashing, Water Quality | Intervention Type: BEHAVIORAL; Name: Sanitation; Assigned to Arm(s): Combined Water, Sanitation, and Handwashing, Nutrition + Combined Water, Sanitation, and Handwashing, Sanitation | Intervention Type: BEHAVIORAL; Name: Handwashing; Assigned to Arm(s): Combined Water, Sanitation, and Handwashing, Handwashing, Nutrition + Combined Water, Sanitation, and Handwashing | Intervention Type: DIETARY_SUPPLEMENT; Name: Nutrition; Assigned to Arm(s): Nutrition, Nutrition + Combined Water, Sanitation, and Handwashing

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients
Brief Summary: To assess efficacy of bronchoscopic lung volume reduction in Korean emphysema patients


Options:
A: Arm Label: Lung volume reduction coïl treatment; Type: EXPERIMENTAL; Interventions: Procedure: Lung volume reduction coïl treatment, Other: Regular medical treatment | Arm Label: Regular Medical Treatment; Type: OTHER; Interventions: Other: Regular medical treatment | Intervention Type: PROCEDURE; Name: Lung volume reduction coïl treatment; Assigned to Arm(s): Lung volume reduction coïl treatment | Intervention Type: OTHER; Name: Regular medical treatment; Assigned to Arm(s): Lung volume reduction coïl treatment, Regular Medical Treatment
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: IBV® Valve System | Arm Label: 2; Type: SHAM_COMPARATOR; Interventions: Device: IBV® Valve System | Intervention Type: DEVICE; Name: IBV® Valve System; Assigned to Arm(s): 1, 2
C: Arm Label: BTVA; Type: EXPERIMENTAL; Interventions: Device: BTVA System | Intervention Type: DEVICE; Name: BTVA System; Assigned to Arm(s): BTVA
D: Arm Label: Endobronchial valve:; Type: EXPERIMENTAL; Interventions: Device: Endobronchial valve | Intervention Type: DEVICE; Name: Endobronchial valve; Assigned to Arm(s): Endobronchial valve:

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Aim was to investigate efficacy of current treatments - water, chewing gum, and olive oil, in resolving postoperative ileus.


Options:
A: Arm Label: 1.; Type: ACTIVE_COMPARATOR; Interventions: Other: Trident sugarless chewing gum. | Arm Label: 2.; Type: PLACEBO_COMPARATOR; Interventions: Other: One control group (these do not chew gum). | Intervention Type: OTHER; Name: Trident sugarless chewing gum.; Assigned to Arm(s): 1. | Intervention Type: OTHER; Name: One control group (these do not chew gum).; Assigned to Arm(s): 2.
B: Arm Label: Standard postoperative care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Chewing gum arm; Type: EXPERIMENTAL; Interventions: Other: Chewing gum | Intervention Type: OTHER; Name: Chewing gum; Assigned to Arm(s): Chewing gum arm
C: Arm Label: major surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: minor surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: ileostomy and colostomy; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: other surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil and chewing gum; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: chewing gum; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: water; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery
D: Arm Label: Treatment arm: coffee; Type: ACTIVE_COMPARATOR; Interventions: Other: Postoperative coffee | Arm Label: Water arm; Type: PLACEBO_COMPARATOR; Interventions: Other: water | Intervention Type: OTHER; Name: Postoperative coffee; Assigned to Arm(s): Treatment arm: coffee | Intervention Type: OTHER; Name: water; Assigned to Arm(s): Water arm

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Placebo Controlled Trial of Indomethacin for Tocolysis
Brief Summary: Indomethacin for tocolysis for 48 hours vs placebo


Options:
A: Arm Label: YTP(ritodrine) arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: YTP(Ritodrine) | Arm Label: MgSO4 arm; Type: EXPERIMENTAL; Interventions: Drug: MgSO4 | Intervention Type: DRUG; Name: MgSO4; Assigned to Arm(s): MgSO4 arm | Intervention Type: DRUG; Name: YTP(Ritodrine); Assigned to Arm(s): YTP(ritodrine) arm
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine extended release | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Nifedipine extended release; Assigned to Arm(s): A
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Indomethacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): Indomethacin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine 20 Mg | Arm Label: Ritodrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ritodrine Oral Tablet | Intervention Type: DRUG; Name: Nifedipine 20 Mg; Assigned to Arm(s): Nifedipine | Intervention Type: DRUG; Name: Ritodrine Oral Tablet; Assigned to Arm(s): Ritodrine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
Brief Summary: To evaluate the feasibility, tolerability and efficacy of Magnetic Seizure Therapy (MST) in elderly patients with a major depressive episode, who are randomly assigned to receive an acute course of MST or ECT.

The investigators hypothesize:

1. MST and ECT will have similar antidepressant efficacy
2. MST will have less post-treatment amnesia than ECT as reflected in a primary measures of anterograde and retrograde amnesia following the acute treatment phase.
3. At follow up, MST will show a lesser degree of persisting deficit in measures of retrograde amnesia than ECT.


Options:
A: Arm Label: magnetic seizure therapy; Type: EXPERIMENTAL; Interventions: Device: Magpro X100 + Option, Other: treatment as usual (TAU) | Arm Label: electroconvulsive therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: ThymatronSystem Ⅳ Electroconvulsive System, Other: treatment as usual (TAU) | Intervention Type: DEVICE; Name: Magpro X100 + Option; Assigned to Arm(s): magnetic seizure therapy | Intervention Type: DEVICE; Name: ThymatronSystem Ⅳ Electroconvulsive System; Assigned to Arm(s): electroconvulsive therapy | Intervention Type: OTHER; Name: treatment as usual (TAU); Assigned to Arm(s): electroconvulsive therapy, magnetic seizure therapy
B: Arm Label: Magnetic Seizure Therapy (MST); Type: EXPERIMENTAL; Interventions: Device: Tonica MagPro MST | Arm Label: Electroconvulsive Therapy (ECT); Type: ACTIVE_COMPARATOR; Interventions: Device: Thymatron | Intervention Type: DEVICE; Name: Thymatron; Assigned to Arm(s): Electroconvulsive Therapy (ECT) | Intervention Type: DEVICE; Name: Tonica MagPro MST; Assigned to Arm(s): Magnetic Seizure Therapy (MST)
C: Arm Label: MST; Type: EXPERIMENTAL; Interventions: Device: Magstim Theta | Arm Label: ECT; Type: ACTIVE_COMPARATOR; Interventions: Device: Thymatron | Intervention Type: DEVICE; Name: Thymatron; Assigned to Arm(s): ECT | Intervention Type: DEVICE; Name: Magstim Theta; Assigned to Arm(s): MST
D: Arm Label: Magnetic Seizure Therapy (MST); Type: EXPERIMENTAL; Interventions: Device: MagVenture MagPro MST | Arm Label: RUL ECT; Type: ACTIVE_COMPARATOR; Interventions: Biological: RUL ECT | Intervention Type: DEVICE; Name: MagVenture MagPro MST; Assigned to Arm(s): Magnetic Seizure Therapy (MST) | Intervention Type: BIOLOGICAL; Name: RUL ECT; Assigned to Arm(s): RUL ECT

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial
Brief Summary: To determine whether shared decision making (SDM) intervention improves patient satisfaction in patients with first-admission schizophrenia compared with usual care.


Options:
A: Arm Label: Shared Decision Making; Type: EXPERIMENTAL; Interventions: Behavioral: Shared Decision Making | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Shared Decision Making; Assigned to Arm(s): Shared Decision Making
B: Arm Label: Using Power Up; Type: EXPERIMENTAL; Interventions: Behavioral: Shared Decision Making tool | Arm Label: Not using Power Up; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Shared Decision Making tool; Assigned to Arm(s): Using Power Up
C: Arm Label: Standard Resource Sheet; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Standard Resource Sheet | Arm Label: Electronic Patient Decision Aid; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Electronic Patient Decision Aid, Behavioral: Standard Resource Sheet | Intervention Type: BEHAVIORAL; Name: Electronic Patient Decision Aid; Assigned to Arm(s): Electronic Patient Decision Aid | Intervention Type: BEHAVIORAL; Name: Standard Resource Sheet; Assigned to Arm(s): Electronic Patient Decision Aid, Standard Resource Sheet
D: Arm Label: Decision aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Decision Aid | Arm Label: Normal care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision aid

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of an Educational Group Intervention in Primary Care to Maintain Exclusive Breastfeeding. Cluster Randomised Clinical Trial. PROLACT Study.
Brief Summary: Hypothesis: An educational intervention increases the proportion of mother-infant pairs using exclusive breastfeeding


Options:
A: Arm Label: eHealth Intervention; Type: EXPERIMENTAL; Interventions: Other: eHealth Breastfeeding Co-parenting Resource | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: eHealth Breastfeeding Co-parenting Resource; Assigned to Arm(s): eHealth Intervention
B: Arm Label: Self-monitoring of BF and intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Self-monitoring of BF and intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-monitoring of BF and intervention; Assigned to Arm(s): Self-monitoring of BF and intervention
C: Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention group | Arm Label: Controll group; Type: OTHER; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Intervention group; Assigned to Arm(s): intervention group | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Controll group
D: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Simulation breastfeeding education | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Simulation breastfeeding education; Assigned to Arm(s): Intervention Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Surgical Skin Preps During Cesarean Deliveries
Brief Summary: In women that undergo non-emergency cesarean delivery, we are comparing the skin preparation solutions for best outcome of surgical site infection. The three different solutions are: Group 1: Iodine povidone based skin preparation solution. Group 2: Chlorhexidine based skin preparation solution or Group 3: Combination usage of iodine povidone and chlorhexidine based skin preparation solutions. Women are prospectively randomized to one of the three groups and followed until thier postpartum visit at 6-8 weeks following delivery.


Options:
A: Arm Label: Chlorhexidine Gluconate; Type: EXPERIMENTAL; Interventions: Drug: Chlorhexidine Gluconate | Arm Label: Povidone-Iodine Scrub and Paint; Type: EXPERIMENTAL; Interventions: Drug: Povidone-Iodine Scrub and Paint | Intervention Type: DRUG; Name: Chlorhexidine Gluconate; Assigned to Arm(s): Chlorhexidine Gluconate | Intervention Type: DRUG; Name: Povidone-Iodine Scrub and Paint; Assigned to Arm(s): Povidone-Iodine Scrub and Paint
B: Arm Label: Combination iodine and chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Combination iodine and chlorhexidine | Arm Label: Chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine | Arm Label: Iodine povidone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Iodine povidone | Intervention Type: DRUG; Name: Iodine povidone; Assigned to Arm(s): Iodine povidone | Intervention Type: DRUG; Name: Chlorhexidine; Assigned to Arm(s): Chlorhexidine | Intervention Type: DRUG; Name: Combination iodine and chlorhexidine; Assigned to Arm(s): Combination iodine and chlorhexidine
C: Arm Label: Chlorhexidine-alcohol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Chlorhexidine-alcohol | Arm Label: Povidine-iodine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Povidine-iodine | Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sterile saline | Intervention Type: DRUG; Name: Chlorhexidine-alcohol; Assigned to Arm(s): Chlorhexidine-alcohol | Intervention Type: DRUG; Name: Povidine-iodine; Assigned to Arm(s): Povidine-iodine | Intervention Type: DRUG; Name: Sterile saline; Assigned to Arm(s): Saline
D: Arm Label: Chlorhexidine gluconate vaginal scrub and cloth; Type: EXPERIMENTAL; Interventions: Drug: 2% chlorhexidine gluconate cloth, Drug: 4% Chlorhexidine gluconate vaginal scrub | Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: 2% chlorhexidine gluconate cloth | Intervention Type: DRUG; Name: 2% chlorhexidine gluconate cloth; Assigned to Arm(s): Chlorhexidine gluconate vaginal scrub and cloth, Standard Treatment | Intervention Type: DRUG; Name: 4% Chlorhexidine gluconate vaginal scrub; Assigned to Arm(s): Chlorhexidine gluconate vaginal scrub and cloth

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Brief Summary: The purpose of the study was to evaluate the efficacy, safety and tolerability of intravenous infusion of serelaxin, when added to standard therapy, in acute heart failure (AHF) patients.


Options:
A: Arm Label: Continuous Furosemide Infusion; Type: N/A; Interventions: Drug: Continuous Furosemide Infusion | Arm Label: Intermittent Furosemide Infusion; Type: N/A; Interventions: Drug: Intermittent Furosemide Infusion | Intervention Type: DRUG; Name: Continuous Furosemide Infusion; Assigned to Arm(s): Continuous Furosemide Infusion | Intervention Type: DRUG; Name: Intermittent Furosemide Infusion; Assigned to Arm(s): Intermittent Furosemide Infusion
B: Arm Label: Serelaxin (RLX030); Type: EXPERIMENTAL; Interventions: Drug: RLX030 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: RLX030; Assigned to Arm(s): Serelaxin (RLX030) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Drug: loop diuretic | Arm Label: Usual care plus tolvaptan; Type: ACTIVE_COMPARATOR; Interventions: Drug: loop diuretic, Drug: tolvaptan | Arm Label: ultrafiltration; Type: ACTIVE_COMPARATOR; Interventions: Procedure: ultrafiltration | Intervention Type: DRUG; Name: loop diuretic; Assigned to Arm(s): Usual care plus tolvaptan, usual care | Intervention Type: DRUG; Name: tolvaptan; Assigned to Arm(s): Usual care plus tolvaptan | Intervention Type: PROCEDURE; Name: ultrafiltration; Assigned to Arm(s): ultrafiltration
D: Arm Label: Infusional drug treatment; Type: ACTIVE_COMPARATOR; Interventions: Drug: Furosemide or Furosemide and Dopamine | Arm Label: Ultrafiltration; Type: EXPERIMENTAL; Interventions: Device: Ultrafiltration | Intervention Type: DRUG; Name: Furosemide or Furosemide and Dopamine; Assigned to Arm(s): Infusional drug treatment | Intervention Type: DEVICE; Name: Ultrafiltration; Assigned to Arm(s): Ultrafiltration

Answer: B